Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07525258

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Alcohol Use Disorder Alcohol-Related Disorders Alcohol-associated Liver Disease Alcoholism Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale School of Medicine/Yale-New Haven Health

New Haven, Connecticut, 06520, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.

Exclusion criteria

  • Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.

Treatment and study plan

Implementation Intervention

Behavioral

A multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested.

Primary outcomes

  1. Feasibility

    Time frame: 12 months

    Percentage of clinicians enrolled out of all recruited

Secondary outcomes

  1. Acceptability

    Time frame: 12 months

    Percentage of clinicians that attend the educational workshops and utilize implementation tools.

Study contacts

Contact information is provided by the study sponsor or research team.

Lamia Haque, MD MPH

CONTACT

[email protected]

(203) 777-0304

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Official study title

Feasibility and Acceptability of a Novel Implementation Intervention to Promote Alcohol Use Disorder Treatment in Hepatology Clinics

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Apr 13, 2026
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.